出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2023年7月
ラベルフリー検出市場 : 製品＆サービス [機器、消耗品 (バイオセンサーチップ、マイクロプレート)、ソフトウェア]、テクノロジー (表面プラズモン共鳴)、用途 (ヒット確認、リード生成)、エンドユーザー (製薬、CRO) 、地域別 – 2028年までの世界予測
Label Free Detection Market by Product & Service (Instruments, Consumables (Biosensor Chips, Microplates), Software), Technology (Surface Plasmon Resonance), Application (Hit Confirmation, Lead Generation), End User (Pharma, CROs) & Region – Global Forecast to 2028
| ページ数 | 251 |
| 図表数 | 261 |
| 種別 | 英文調査報告書 |
| 価格 |
The global label-free detection market is projected to reach USD 863 million by 2028 from USD 570 million in 2023, at a CAGR of 8.7% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the rising industry-academia collaborations for research. For instance, In June 2023, Waters Corporation announced a multi-year research collaboration with Princeton University that will enable scientists, faculty, and students to work together to bring their diverse skills and backgrounds to solve complex challenges in biochemistry and materials science. Under the new agreement, the Waters-Princeton collaboration will bring together academic and industry researchers to tap into knowledge and expertise from various scientific domains and disciplines to identify and solve problems that matter. One such research project will focus on novel media for purification to help advance drug development and discovery.
“The biosensor chips segment accounted for the largest share by consumables during the forecast period”
In 2022, biosensor chips segment accounted for the largest share by consumables in the global label-free detection market. Biosensors are important tools in the fields of biochemistry and biomedical engineering because they provide a platform for the detection of various analytes. Currently, label-free biosensors are widely used in proteomics and biomolecular interaction studies, as the detection of the chemical or biological agent by the transducer does not rely on dyes, enzymes, or radiolabels. Conventionally, many small molecules are detected by chromatographic methods, which are usually costly, bulky, and require expertise. Biosensors offer a cheaper and faster alternative. Some advantages of biosensors over classical methods for small-molecule detection include real-time monitoring, high specificity, fast response times, reduced consumption of organic solvents and sample manipulation, portability, compactness, and easy operation.
“Europe: The second largest region in the label-free detection market”
Europe accounted for the second-largest market for label-free detection market after North America. The European label-free detection market has witnessed significant growth in recent years, driven by various factors that have propelled its expansion. Europe is at the forefront of developing and adopting emerging technologies in the field of label-free detection market. This includes advancements in label-free detection technologies. The adoption of these innovative technologies accelerates the progress of viral vector and plasmid DNA manufacturing research and expands its applications. Additionally, Europe offers comprehensive training and education programs in label-free detection technologies. Universities, research institutes, and organizations provide funding, and conferences to enhance the knowledge and skills of scientists and researchers. The availability of funding promotes the adoption and utilization of of label-free detection technologies in Europe.
The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 80% and Demand Side 20%
• By Designation: C-level – 55%, D-level – 20%, and Others – 25%
• By Region: North America -45%, Europe -20%, Asia-Pacific -25%, Latin America and Middle East & Africa- 10%
List of Companies Profiled in the Report:
• Danaher (US)
• Sartorius AG (Germany)
• Waters Corporation (US)
• PerkinElmer, Inc. (US)
• AMETEK, Inc. (US)
• HORIBA, Ltd. (Japan)
• Spectris (UK)
• METTLER TOLEDO International Inc., (US)
• Agilent Technologies, Inc. (US)
• Shimadzu Corporation (Japan)
• Hitachi High-Tech Corporation (Japan)
• Attana AB (Sweden)
• Bruker (US)
• NanoTemper Technologies GmbH (Germany)
• Affinité Instruments (Canada)
• Biosensing Instrument (US)
• Unchained Labs (US)
• BioNavis Ltd. (Finland)
• Carterra, Inc. (US)
• Nicoya (Canada)
• BiOptix Analytical LLC (US)
• Plexera Bioscience (US)
• XanTec Bioanalytics GmbH (Germany)
• lino Biotech AG (Switzerland)
• KEP Technologies (France)
Research Coverage:
This report provides a detailed picture of the label-free detection market. It aims at estimating the size and future growth potential of the market across different segments such as the product & service, technology, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges
The report provides insights on the following pointers:
• Analysis of key drivers (Introduction of technologically advanced products, growing number of drug discovery programs through academic-industrial partnerships and high sensitivity of label-free technologies), restraints (High cost of instruments), opportunities (Growing life science research activities in emerging markets), and challenges (Shortage of skilled professionals) influencing the growth of the market.
• Product and Service Development/Innovation: Detailed insights on newly launched products and technological assessment of the label-free detection market
• Market Development: Comprehensive information about lucrative markets – the report analyses the market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the label-free detection market
• Competitive Assessment: In-depth assessment of market shares, growth strategies and products offerings of leading players like Danaher (US), Sartorius AG (Germany), Waters Corporation (US), PerkinElmer, Inc. (US), AMETEK, Inc. (US), HORIBA, Ltd. (Japan), Spectris (UK), METTLER TOLEDO International Inc., (US), Agilent Technologies, Inc. (US), Shimadzu Corporation (Japan), Hitachi High-Tech Corporation (Japan), Attana AB (Sweden), Bruker (US), NanoTemper Technologies GmbH (Germany), Affinité Instruments (Canada), Biosensing Instrument (US), Unchained Labs (US), BioNavis Ltd. (Finland), Carterra, Inc. (US), Nicoya (Canada), BiOptix Analytical LLC (US), Plexera Bioscience (US), XanTec Bioanalytics GmbH (Germany), lino Biotech AG (Switzerland), and KEP Technologies (France)., and among others in the market.
目次
1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 32
1.2.1 INCLUSIONS AND EXCLUSIONS 32
1.3 MARKET SCOPE 33
1.3.1 MARKETS COVERED 33
1.3.2 YEARS CONSIDERED 34
1.3.3 CURRENCY CONSIDERED 34
1.4 LIMITATIONS 34
1.5 STAKEHOLDERS 35
1.6 SUMMARY OF CHANGES 35
1.6.1 RECESSION IMPACT 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH DATA 37
FIGURE 1 LABEL-FREE DETECTION MARKET: RESEARCH DESIGN 37
2.1.1 SECONDARY RESEARCH 38
2.1.2 PRIMARY RESEARCH 38
FIGURE 2 LABEL-FREE DETECTION MARKET: BREAKDOWN OF PRIMARIES 39
2.2 MARKET SIZE ESTIMATION 40
FIGURE 3 LABEL-FREE DETECTION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022 40
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1—REVENUE SHARE ANALYSIS (2022) 41
FIGURE 5 KEY INDUSTRY INSIGHTS 42
2.3 GROWTH FORECAST 43
FIGURE 6 LABEL-FREE DETECTION MARKET: CAGR PROJECTIONS, 2023–2028 44
FIGURE 7 LABEL-FREE DETECTION MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 44
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 45
FIGURE 8 DATA TRIANGULATION METHODOLOGY 45
2.5 RESEARCH ASSUMPTIONS 45
2.6 RISK ANALYSIS 46
2.7 RECESSION IMPACT ANALYSIS 46
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (%GROWTH) 46
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 47
TABLE 3 US HEALTH EXPENDITURE, 2023–2030 (USD MILLION) 47
3 EXECUTIVE SUMMARY 48
FIGURE 9 LABEL-FREE DETECTION MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION) 48
FIGURE 10 LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION) 49
FIGURE 11 LABEL-FREE DETECTION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 50
FIGURE 12 LABEL-FREE DETECTION MARKET, BY END USER, 2023 VS. 2028 (USD MILLION) 50
FIGURE 13 GEOGRAPHICAL SNAPSHOT: LABEL-FREE DETECTION MARKET 51
4 PREMIUM INSIGHTS 52
4.1 LABEL-FREE DETECTION MARKET OVERVIEW 52
FIGURE 14 GROWING NUMBER OF DRUG DISCOVERY PROGRAMS TO DRIVE MARKET 52
4.2 NORTH AMERICA: LABEL-FREE DETECTION MARKET SHARE, BY PRODUCT & SERVICE AND COUNTRY (2022) 53
FIGURE 15 INSTRUMENTS DOMINATED NORTH AMERICAN LABEL-FREE DETECTION MARKET IN 2022 53
4.3 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY END USER AND COUNTRY (2022) 54
FIGURE 16 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES SEGMENT ACCOUNTED FOR LARGEST SHARE OF APAC MARKET IN 2022 54
4.4 LABEL-FREE DETECTION MARKET SHARE, BY END USER, 2022 54
FIGURE 17 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022 54
4.5 LABEL-FREE DETECTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 55
FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE IN LABEL-FREE DETECTION MARKET FROM 2023 TO 2028 55
5 MARKET OVERVIEW 56
5.1 INTRODUCTION 56
5.2 MARKET DYNAMICS 56
FIGURE 19 LABEL-FREE DETECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES AND TRENDS 56
TABLE 4 LABEL-FREE DETECTION MARKET: IMPACT ANALYSIS 57
5.2.1 DRIVERS 57
5.2.1.1 Technological advancements in label-free detection 57
5.2.1.2 Growing academic-industrial partnerships for drug discovery programs 58
5.2.1.3 High sensitivity of label-free technologies 58
5.2.2 RESTRAINTS 59
5.2.2.1 High cost of instruments 59
5.2.3 OPPORTUNITIES 59
5.2.3.1 Growing life sciences research in emerging economies 59
5.2.4 CHALLENGES 60
5.2.4.1 Sample complexity and interference 60
5.2.5 TRENDS 60
5.2.5.1 Rising pharmaceutical outsourcing 60
5.2.5.2 Increasing applications of label-free electrochemical sensing platforms 61
5.3 INDICATIVE PRICING ANALYSIS 61
TABLE 5 PRICING ANALYSIS FOR PRODUCTS 62
5.4 VALUE CHAIN ANALYSIS 62
FIGURE 20 VALUE CHAIN ANALYSIS: MANUFACTURING PHASES ADD MAXIMUM VALUE 63
5.5 ECOSYSTEM ANALYSIS 63
FIGURE 21 ECOSYSTEM ANALYSIS: LABEL-FREE DETECTION MARKET 64
TABLE 6 OVERALL MARKET ECOSYSTEM: ROLE OF KEY PLAYERS AND ENTITIES 64
5.6 PORTER’S FIVE FORCES ANALYSIS 66
TABLE 7 LABEL-FREE DETECTION MARKET: PORTER’S FIVE FORCES ANALYSIS 66
5.6.1 THREAT OF NEW ENTRANTS 66
5.6.2 THREAT OF SUBSTITUTES 66
5.6.3 BARGAINING POWER OF BUYERS 66
5.6.4 BARGAINING POWER OF SUPPLIERS 66
5.6.5 INTENSITY OF COMPETITIVE RIVALRY 67
5.7 TECHNOLOGY ANALYSIS 67
TABLE 8 TECHNOLOGY ANALYSIS: BIOSENSOR ASSAYS VS. ISOTHERMAL TITRATION CALORIMETRY 67
5.8 PATENT ANALYSIS 68
FIGURE 22 TOP PATENT OWNERS IN LABEL-FREE DETECTION, JANUARY 2013– JULY 2023 68
5.9 REGULATORY SCENARIO ANALYSIS 69
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 9 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 10 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 70
TABLE 12 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
TABLE 13 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 71
5.10 KEY CONFERENCES AND EVENTS IN 2023–2024 72
TABLE 14 LABEL-FREE DETECTION MARKET: LIST OF CONFERENCES AND EVENTS 72
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 72
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 72
FIGURE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF LABEL-FREE DETECTION TECHNOLOGIES 73
5.11.2 BUYING CRITERIA FOR LABEL-FREE DETECTION PRODUCTS 73
FIGURE 24 KEY BUYING CRITERIA FOR END USERS 73
6 LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE 74
6.1 INTRODUCTION 75
TABLE 15 LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 75
6.2 INSTRUMENTS 75
6.2.1 TECHNOLOGICAL ADVANCEMENTS IN LABEL-FREE DETECTION SYSTEMS TO DRIVE INSTRUMENTS MARKET 75
TABLE 16 LABEL-FREE DETECTION INSTRUMENTS OFFERED, BY COMPANY 76
TABLE 17 LABEL-FREE DETECTION INSTRUMENTS MARKET, BY REGION, 2021–2028 (USD MILLION) 77
TABLE 18 NORTH AMERICA: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 77
TABLE 19 EUROPE: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78
TABLE 20 ASIA PACIFIC: LABEL-FREE DETECTION INSTRUMENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 78
6.3 CONSUMABLES 78
TABLE 21 LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 79
TABLE 22 LABEL-FREE DETECTION CONSUMABLES MARKET, BY REGION, 2021–2028 (USD MILLION) 79
TABLE 23 NORTH AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 79
TABLE 24 EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80
TABLE 25 ASIA PACIFIC: LABEL-FREE DETECTION CONSUMABLES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 80
6.3.1 BIOSENSOR CHIPS 80
6.3.1.1 High specificity and real-time monitoring to boost demand 80
TABLE 26 BIOSENSOR CHIPS OFFERED, BY COMPANY 81
TABLE 27 BIOSENSOR CHIPS MARKET, BY REGION, 2021–2028 (USD MILLION) 82
TABLE 28 NORTH AMERICA: BIOSENSOR CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 82
TABLE 29 EUROPE: BIOSENSOR CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
TABLE 30 ASIA PACIFIC: BIOSENSOR CHIPS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 83
6.3.2 MICROPLATES 83
6.3.2.1 Low cost and wide usage to drive market 83
TABLE 31 MICROPLATES OFFERED, BY COMPANY 84
TABLE 32 MICROPLATES MARKET, BY REGION, 2021–2028 (USD MILLION) 85
TABLE 33 NORTH AMERICA: MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 34 EUROPE: MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 85
TABLE 35 ASIA PACIFIC: MICROPLATES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 86
6.3.3 REAGENTS & KITS 86
6.3.3.1 Availability of ready-to-use kits for assay development to drive market 86
TABLE 36 REAGENTS & KITS OFFERED, BY COMPANY 87
TABLE 37 REAGENTS & KITS MARKET, BY REGION, 2021–2028 (USD MILLION) 88
TABLE 38 NORTH AMERICA: REAGENTS & KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 88
TABLE 39 EUROPE: REAGENTS & KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
TABLE 40 ASIA PACIFIC: REAGENTS & KITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 89
6.4 SOFTWARE & SERVICES 89
6.4.1 AUTOMATION IN LABEL-FREE DETECTION TO DRIVE DEMAND 89
TABLE 41 SOFTWARE & SERVICES OFFERED, BY COMPANY 90
TABLE 42 LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 91
TABLE 43 NORTH AMERICA: LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 91
TABLE 44 EUROPE: LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
TABLE 45 ASIA PACIFIC: LABEL-FREE DETECTION SOFTWARE & SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 92
7 LABEL-FREE DETECTION MARKET, BY TECHNOLOGY 93
7.1 INTRODUCTION 94
TABLE 46 LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 94
7.2 SURFACE PLASMON RESONANCE 94
7.2.1 GROWING USE OF SPR TECHNOLOGY IN AFFINITY AND KINETIC STUDIES TO FUEL MARKET GROWTH 94
TABLE 47 LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE, BY REGION, 2021–2028 (USD MILLION) 95
TABLE 48 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION) 95
TABLE 49 EUROPE: LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION) 96
TABLE 50 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2021–2028 (USD MILLION) 96
7.3 DIFFERENTIAL SCANNING CALORIMETRY 96
7.3.1 WIDE USAGE IN DRUG DISCOVERY AND DEVELOPMENT 96
TABLE 51 LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY, BY REGION, 2021–2028 (USD MILLION) 97
TABLE 52 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION) 97
TABLE 53 EUROPE: LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION) 98
TABLE 54 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR DIFFERENTIAL SCANNING CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION) 98
7.4 BIO-LAYER INTERFEROMETRY 98
7.4.1 MICROFLUIDICS-FREE CHARACTERISTIC TO BOOST ADOPTION 98
TABLE 55 LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY, BY REGION, 2021–2028 (USD MILLION) 99
TABLE 56 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY, BY COUNTRY, 2021–2028 (USD MILLION) 99
TABLE 57 EUROPE: LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY, BY COUNTRY, 2021–2028 (USD MILLION) 100
TABLE 58 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR BIO-LAYER INTERFEROMETRY, BY COUNTRY, 2021–2028 (USD MILLION) 100
7.5 ISOTHERMAL TITRATION CALORIMETRY 100
7.5.1 SUPPORT FOR BETTER HIT SELECTION AND LEAD OPTIMIZATION TO DRIVE ADOPTION 100
TABLE 59 LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY, BY REGION, 2021–2028 (USD MILLION) 101
TABLE 60 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION) 101
TABLE 61 EUROPE: LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION) 102
TABLE 62 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR ISOTHERMAL TITRATION CALORIMETRY, BY COUNTRY, 2021–2028 (USD MILLION) 102
7.6 OTHER TECHNOLOGIES 102
TABLE 63 LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021–2028 (USD MILLION) 103
TABLE 64 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 65 EUROPE: LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 66 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021–2028 (USD MILLION) 104
8 LABEL-FREE DETECTION MARKET, BY APPLICATION 105
8.1 INTRODUCTION 106
TABLE 67 LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 106
8.2 BINDING KINETICS 106
8.2.1 BINDING KINETICS TO HOLD LARGEST MARKET SHARE TILL 2028 106
TABLE 68 LABEL-FREE DETECTION MARKET FOR BINDING KINETICS, BY REGION, 2021–2028 (USD MILLION) 107
TABLE 69 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR BINDING KINETICS, BY COUNTRY, 2021–2028 (USD MILLION) 107
TABLE 70 EUROPE: LABEL-FREE DETECTION MARKET FOR BINDING KINETICS, BY COUNTRY, 2021–2028 (USD MILLION) 108
TABLE 71 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR BINDING KINETICS, BY COUNTRY, 2021–2028 (USD MILLION) 108
8.3 BINDING THERMODYNAMICS 108
8.3.1 WIDE APPLICATIONS IN BASIC RESEARCH TO DRIVE MARKET 108
TABLE 72 LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMICS, BY REGION, 2021–2028 (USD MILLION) 109
TABLE 73 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMICS, BY COUNTRY, 2021–2028 (USD MILLION) 109
TABLE 74 EUROPE: LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMICS, BY COUNTRY, 2021–2028 (USD MILLION) 110
TABLE 75 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR BINDING THERMODYNAMICS, BY COUNTRY, 2021–2028 (USD MILLION) 110
8.4 HIT CONFIRMATION 110
8.4.1 NEED TO STUDY BIOMOLECULAR INTERACTIONS IN NATIVE STATES TO BOOST USAGE 110
TABLE 76 LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION, BY REGION, 2021–2028 (USD MILLION) 111
TABLE 77 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION, BY COUNTRY, 2021–2028 (USD MILLION) 111
TABLE 78 EUROPE: LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION, BY COUNTRY, 2021–2028 (USD MILLION) 112
TABLE 79 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR HIT CONFIRMATION, BY COUNTRY, 2021–2028 (USD MILLION) 112
8.5 LEAD GENERATION 112
8.5.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE APPLICATIONS IN DRUG CANDIDATE SELECTION 112
TABLE 80 LABEL-FREE DETECTION MARKET FOR LEAD GENERATION, BY REGION, 2021–2028 (USD MILLION) 113
TABLE 81 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR LEAD GENERATION, BY COUNTRY, 2021–2028 (USD MILLION) 113
TABLE 82 EUROPE: LABEL-FREE DETECTION MARKET FOR LEAD GENERATION, BY COUNTRY, 2021–2028 (USD MILLION) 114
TABLE 83 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR LEAD GENERATION, BY COUNTRY, 2021–2028 (USD MILLION) 114
8.6 ENDOGENOUS RECEPTOR DETECTION 114
8.6.1 HIGH SENSITIVITY OF LABEL-FREE ASSAYS TO DRIVE ADOPTION 114
TABLE 84 LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION, BY REGION, 2021–2028 (USD MILLION) 115
TABLE 85 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION, BY COUNTRY, 2021–2028 (USD MILLION) 115
TABLE 86 EUROPE: LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION, BY COUNTRY, 2021–2028 (USD MILLION) 116
TABLE 87 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR ENDOGENOUS RECEPTOR DETECTION, 2021–2028 (USD MILLION) 116
8.7 OTHER APPLICATIONS 116
TABLE 88 LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION) 117
TABLE 89 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 117
TABLE 90 EUROPE: LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION) 118
TABLE 91 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR OTHER APPLICATIONS, 2021–2028 (USD MILLION) 118
9 LABEL-FREE DETECTION MARKET, BY END USER 119
9.1 INTRODUCTION 120
TABLE 92 LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 120
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 120
9.2.1 PHARMA & BIOTECH COMPANIES TO HOLD LARGEST MARKET SHARE TILL 2028 120
TABLE 93 LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION) 121
TABLE 94 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 95 EUROPE: LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 122
TABLE 96 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION) 122
9.3 ACADEMIC & RESEARCH INSTITUTES 122
9.3.1 RISING INDUSTRY-ACADEMIA RESEARCH COLLABORATIONS TO DRIVE MARKET 122
TABLE 97 LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION) 123
TABLE 98 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 123
TABLE 99 EUROPE: LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 124
TABLE 100 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION) 124
9.4 CONTRACT RESEARCH ORGANIZATIONS 124
9.4.1 INCREASING PHARMACEUTICAL OUTSOURCING TO DRIVE MARKET GROWTH 124
TABLE 101 LABEL-FREE DETECTION MARKET FOR CROS, BY REGION, 2021–2028 (USD MILLION) 125
TABLE 102 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION) 125
TABLE 103 EUROPE: LABEL-FREE DETECTION MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION) 126
TABLE 104 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR CROS, BY COUNTRY, 2021–2028 (USD MILLION) 126
9.5 OTHER END USERS 126
TABLE 105 LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION) 127
TABLE 106 NORTH AMERICA: LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 127
TABLE 107 EUROPE: LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 128
TABLE 108 ASIA PACIFIC: LABEL-FREE DETECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION) 128
10 LABEL-FREE DETECTION MARKET, BY REGION 129
10.1 INTRODUCTION 130
TABLE 109 LABEL-FREE DETECTION MARKET, BY REGION, 2021–2028 (USD MILLION) 130
10.2 NORTH AMERICA 130
10.2.1 NORTH AMERICA: RECESSION IMPACT 131
FIGURE 25 NORTH AMERICA: LABEL-FREE DETECTION MARKET SNAPSHOT 132
TABLE 110 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 133
TABLE 111 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 133
TABLE 112 NORTH AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 113 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 134
TABLE 114 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 115 NORTH AMERICA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 135
10.2.2 US 135
10.2.2.1 US to dominate label-free detection market in North America 135
TABLE 116 US: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 136
TABLE 117 US: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 118 US: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 136
TABLE 119 US: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 137
TABLE 120 US: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 137
10.2.3 CANADA 137
10.2.3.1 Government initiatives to promote research to support market growth 137
TABLE 121 CANADA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 138
TABLE 122 CANADA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 138
TABLE 123 CANADA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 139
TABLE 124 CANADA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
TABLE 125 CANADA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 140
10.3 EUROPE 140
10.3.1 EUROPE: RECESSION IMPACT 141
TABLE 126 EUROPE: LABEL-FREE DETECTION MARKET BY COUNTRY, 2021–2028 (USD MILLION) 141
TABLE 127 EUROPE: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 142
TABLE 128 EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 142
TABLE 129 EUROPE: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 142
TABLE 130 EUROPE: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 143
TABLE 131 EUROPE: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 143
10.3.2 GERMANY 143
10.3.2.1 Germany to dominate European label-free detection market 143
TABLE 132 GERMANY: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 144
TABLE 133 GERMANY: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 144
TABLE 134 GERMANY: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 145
TABLE 135 GERMANY: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145
TABLE 136 GERMANY: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 146
10.3.3 UK 146
10.3.3.1 Government and private sponsorships for drug discovery services to support market 146
TABLE 137 UK: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 147
TABLE 138 UK: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 147
TABLE 139 UK: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 147
TABLE 140 UK: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 141 UK: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 148
10.3.4 FRANCE 148
10.3.4.1 Favorable funding scenario to drive market 148
TABLE 142 FRANCE: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 149
TABLE 143 FRANCE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 144 FRANCE: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 150
TABLE 145 FRANCE: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 146 FRANCE: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 151
10.3.5 ITALY 151
10.3.5.1 Rising life science R&D to drive market 151
TABLE 147 ITALY: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 152
TABLE 148 ITALY: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 149 ITALY: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 152
TABLE 150 ITALY: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 153
TABLE 151 ITALY: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 153
10.3.6 SPAIN 153
10.3.6.1 Increasing focus on personalized medicines to drive market 153
TABLE 152 SPAIN: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 154
TABLE 153 SPAIN: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 154
TABLE 154 SPAIN: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 155
TABLE 155 SPAIN: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 155
TABLE 156 SPAIN: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 156
10.3.7 REST OF EUROPE 156
TABLE 157 REST OF EUROPE: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 157
TABLE 158 REST OF EUROPE: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 157
TABLE 159 REST OF EUROPE: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 158
TABLE 160 REST OF EUROPE: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 158
TABLE 161 REST OF EUROPE: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 159
10.4 ASIA PACIFIC 159
10.4.1 ASIA PACIFIC: RECESSION IMPACT 159
TABLE 162 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 160
TABLE 163 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 160
TABLE 164 ASIA PACIFIC: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 161
TABLE 165 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 161
TABLE 166 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 162
TABLE 167 ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 162
10.4.2 CHINA 162
10.4.2.1 China to dominate APAC label-free detection market 162
TABLE 168 CHINA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 163
TABLE 169 CHINA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 164
TABLE 170 CHINA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 164
TABLE 171 CHINA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 165
TABLE 172 CHINA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 165
10.4.3 JAPAN 165
10.4.3.1 Robust funding for research to propel market growth 165
TABLE 173 JAPAN: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 166
TABLE 174 JAPAN: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 166
TABLE 175 JAPAN: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 167
TABLE 176 JAPAN: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 167
TABLE 177 JAPAN: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 168
10.4.4 INDIA 168
10.4.4.1 Growing R&D spending by pharma companies and favorable government initiatives to support adoption 168
TABLE 178 INDIA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 169
TABLE 179 INDIA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 169
TABLE 180 INDIA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 170
TABLE 181 INDIA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 170
TABLE 182 INDIA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 171
10.4.5 REST OF ASIA PACIFIC 171
TABLE 183 REST OF ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 172
TABLE 184 REST OF ASIA PACIFIC: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 172
TABLE 185 REST OF ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 173
TABLE 186 REST OF ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 173
TABLE 187 REST OF ASIA PACIFIC: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 174
10.5 LATIN AMERICA 174
10.5.1 RISING ADOPTION OF LABEL-FREE DETECTION TECHNOLOGIES IN BIOTECH & PHARMA SECTORS TO SUPPORT GROWTH 174
10.5.2 LATIN AMERICA: RECESSION IMPACT 175
TABLE 188 LATIN AMERICA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 175
TABLE 189 LATIN AMERICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 175
TABLE 190 LATIN AMERICA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 176
TABLE 191 LATIN AMERICA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 176
TABLE 192 LATIN AMERICA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 177
10.6 MIDDLE EAST & AFRICA 177
10.6.1 GROWING PHARMACEUTICAL INDUSTRY TO DRIVE MARKET 177
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT 178
TABLE 193 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION) 178
TABLE 194 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION CONSUMABLES MARKET, BY TYPE, 2021–2028 (USD MILLION) 178
TABLE 195 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION) 179
TABLE 196 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 179
TABLE 197 MIDDLE EAST & AFRICA: LABEL-FREE DETECTION MARKET, BY END USER, 2021–2028 (USD MILLION) 180
11 COMPETITIVE LANDSCAPE 181
11.1 INTRODUCTION 181
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 182
FIGURE 26 LABEL-FREE DETECTION MARKET: STRATEGIES ADOPTED BY KEY PLAYERS, 2020-2023 182
11.3 MARKET SHARE ANALYSIS 183
FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022 183
TABLE 198 LABEL-FREE DETECTION MARKET: DEGREE OF COMPETITION 183
11.4 REVENUE SHARE ANALYSIS 184
FIGURE 28 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022 185
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 185
FIGURE 29 LABEL-FREE DETECTION MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022 186
11.5.1 STARS 187
11.5.2 EMERGING LEADERS 187
11.5.3 PERVASIVE PLAYERS 187
11.5.4 PARTICIPANTS 187
11.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS 188
11.6.1 COMPANY PRODUCT FOOTPRINT (25 COMPANIES) 188
TABLE 199 PRODUCT FOOTPRINT ANALYSIS 188
11.6.2 COMPANY REGIONAL FOOTPRINT (25 COMPANIES) 189
TABLE 200 REGIONAL FOOTPRINT ANALYSIS 189
11.7 COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 190
FIGURE 30 LABEL-FREE DETECTION MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022 190
11.7.1 PROGRESSIVE COMPANIES 191
11.7.2 RESPONSIVE COMPANIES 191
11.7.3 DYNAMIC COMPANIES 191
11.7.4 STARTING BLOCKS 191
11.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 192
TABLE 201 LABEL-FREE DETECTION MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS 192
TABLE 202 LABEL-FREE DETECTION MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS 193
11.9 COMPETITIVE SCENARIO AND TRENDS 194
11.9.1 PRODUCT LAUNCHES 194
TABLE 203 LABEL-FREE DETECTION MARKET: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023 194
11.9.2 DEALS 195
TABLE 204 LABEL-FREE DETECTION MARKET: DEALS, JANUARY 2020–JUNE 2023 195
11.9.3 OTHER DEVELOPMENTS 195
TABLE 205 LABEL-FREE DETECTION MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023 195
12 COMPANY PROFILES 196
12.1 KEY PLAYERS 196
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 DANAHER 196
TABLE 206 DANAHER: BUSINESS OVERVIEW 196
FIGURE 31 DANAHER: COMPANY SNAPSHOT (2022) 197
12.1.2 SARTORIUS AG 201
TABLE 207 SARTORIUS AG: BUSINESS OVERVIEW 201
FIGURE 32 SARTORIUS AG: COMPANY SNAPSHOT (2022) 202
12.1.3 WATERS CORPORATION 206
TABLE 208 WATERS CORPORATION: BUSINESS OVERVIEW 206
FIGURE 33 WATERS: COMPANY SNAPSHOT (2022) 207
12.1.4 PERKINELMER, INC. 210
TABLE 209 PERKINELMER, INC.: BUSINESS OVERVIEW 210
FIGURE 34 PERKINELMER, INC.: COMPANY SNAPSHOT (2022) 211
12.1.5 AMETEK, INC. 213
TABLE 210 AMETEK, INC.: BUSINESS OVERVIEW 213
FIGURE 35 AMETEK, INC.: COMPANY SNAPSHOT (2022) 214
12.1.6 HORIBA, LTD. 216
TABLE 211 HORIBA, LTD.: BUSINESS OVERVIEW 216
FIGURE 36 HORIBA, LTD.: COMPANY SNAPSHOT (2022) 217
12.1.7 SPECTRIS 219
TABLE 212 SPECTRIS: BUSINESS OVERVIEW 219
FIGURE 37 SPECTRIS: COMPANY SNAPSHOT 220
12.1.8 METTLER TOLEDO INTERNATIONAL, INC. 223
TABLE 213 METTLER TOLEDO INTERNATIONAL, INC.: BUSINESS OVERVIEW 223
FIGURE 38 METTLER TOLEDO INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022) 224
12.1.9 AGILENT TECHNOLOGIES, INC. 226
TABLE 214 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 226
FIGURE 39 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2022) 227
12.1.10 SHIMADZU CORPORATION 230
TABLE 215 SHIMADZU CORPORATION: BUSINESS OVERVIEW 230
FIGURE 40 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2022) 231
12.1.11 HITACHI HIGH-TECH CORPORATION 232
TABLE 216 HITACHI HIGH-TECH CORPORATION: BUSINESS OVERVIEW 232
FIGURE 41 HITACHI HIGH-TECH CORPORATION: COMPANY SNAPSHOT (2022) 233
12.1.12 ATTANA AB 235
TABLE 217 ATTANA AB: BUSINESS OVERVIEW 235
FIGURE 42 ATTANA AB: COMPANY SNAPSHOT (2022) 235
12.1.13 BRUKER 237
TABLE 218 BRUKER: BUSINESS OVERVIEW 237
FIGURE 43 BRUKER: COMPANY SNAPSHOT (2022) 238
12.2 OTHER PLAYERS 240
12.2.1 NANOTEMPER TECHNOLOGIES GMBH 240
12.2.2 AFFINITÉ INSTRUMENTS 241
12.2.3 BIOSENSING INSTRUMENT 242
12.2.4 UNCHAINED LABS 243
12.2.5 BIONAVIS LTD. 244
12.2.6 CARTERRA, INC. 245
12.2.7 NICOYA 246
12.2.8 BIOPTIX ANALYTICAL LLC 247
12.2.9 PLEXERA BIOSCIENCE 248
12.2.10 XANTEC BIOANALYTICS GMBH 249
12.2.11 LINO BIOTECH AG (MILTENYI BIOTEC) 250
12.2.12 KEP TECHNOLOGIES 251
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
13 APPENDIX 252
13.1 DISCUSSION GUIDE 252
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 256
13.3 CUSTOMIZATION OPTIONS 258
13.4 RELATED REPORTS 259
13.5 AUTHOR DETAILS 260